CAFC finds broadly claimed computer memory system eligible under first step of Alice.

Thomas Brown | September 21, 2017

Visual Memory LLC v Nvidia Corporation

August 15, 2017

Before O’Malley, Hughes and Stoll. Precedential Opinion by Stoll, joined by O’Malley; Dissent by Hughes.

Summary:

Visual Memory sued Nvidia for infringement of USP 5,953,740 (the ‘740 patent).  The district court granted Nvidia’s motion to dismiss for failure to state a claim (rule 12(b)(6)) based on patent ineligible subject matter. The CAFC reversed and remanded finding that the computer memory systems claims of the ‘740 satisfied the first step of Alice.


Read More/続きを読む

CAFC agrees with the Board that will.i.am restriction in the identification of goods is meaningless

Kumiko Ide | September 19, 2017

In re I.AM.SYMBOLIC, LLC

August 8, 2017

Before: Prost, Lourie, and Schall. Opinion by Lourie.

Summary:

The Board held, and the CAFC agreed that the will.i.am restriction in the identification of goods, which stated “all associated with William Adams, professionally known as “will.i.am” did not impact on the meaning or the overall commercial impression of the mark.  Further, the will.i.am restriction provided no limitation on the nature of the goods, trade channels, or potential purchasers.  Where the marks are identical, and substantial evidence supports the goods are identical or closely related, the trade channels are identical, and classes of purchasers overlap, the CAFC upheld the Board’s decision affirming the examining attorney’s refusal to register the marks of the Appellant.


Read More/続きを読む

Drug patent survives invalidity challenge based on lack of teaching or suggestion in the art, teaching away, unexpected results and long-felt need

Ryan Chirnomas | August 15, 2017

Millennium Pharmaceuticals Inc. v. Sandoz Inc., et al.

July 17, 2017

Before:  Newman, Mayer and O’Malley.  Opinion: Newman

Summary

The inventors discovered that freeze-drying mannitol with an existing, but unstable, drug resulted in an ester which solved stability and solubility problems of the drug alone.   The patent survived an invalidity challenge since there was no teaching or suggestion of freeze-drying this drug in the presence of mannitol.  Non-obviousness was further bolstered by a teaching away, unexpected results and evidence of a long-felt need.


Read More/続きを読む

A diagnostic method that raises, not patent-eligibility, but written description issues.

Nicolas Seckel | July 24, 2017

Stanford Univ. v. The Chinese Univ. of Hong Kong (Precedential)

June 27, 2017

Before O’Malley, Reyna, and Chen.  Opinion by O’Malley.

Summary:

In interferences involving a patent by Stanford and applications by the Chinese University of Hong Kong, the USPTO found the Stanford patent’s claims unpatentable as lacking written description. The Federal Circuit vacated and remanded. The USPTO was faulted for relying on post-filing date information as evidence of what the person of the art knew at the filing date.


Read More/続きを読む

Next Page »

Subscribe | 登録

Archives

Categories

词典 / 辞書 / 사전
  • dictionary
  • dictionary
  • 英語から日本語

Double click on any word on the page or type a word:

Powered by dictionarist.com